Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

Precursor Ventures

Precursor Ventures does not walk into a room looking for traction. Charles Hudson built it in 2015 to find something earlier, quieter, and far more dangerous to miss. The person before the product. The insight before the spreadsheet. Out of San Francisco, with a deliberately lean team that includes Ashtan Jordan, Marina Girgis, Mia Farnham, Aliya Lakhani, and Danielle Lincoln, the firm moves with the kind of precision you only get after seeing hundreds of zero-to-one moments up close. Hudson’s time at SoftTech VC sharpened that instinct, but Precursor made it a system. In a startup ecosystem obsessed with proof, they specialize in belief with discipline.

The model sounds simple until capital is on the line. Be the first institutional check. Show up when the deck is still evolving and the product is more intention than infrastructure. Precursor writes early checks in the $100K–$500K range, stepping in when uncertainty is still high and signal is still human. Software, hardware, AI, fintech, healthtech, consumer, enterprise, it reads broad, but the filter is tight. Founder-market fit is the wedge. Insight is the currency. In a noisy startup ecosystem, that clarity compounds.

Since launch, that conviction has scaled into 400+ companies. Incredible Health, Healthie, Partake Foods, Bobbie, and Rad AI reflect a pattern of early bets turning into category pressure. Charles Hudson has also backed companies such as The Athletic, Clearco, Juniper Square, Carrot, and Pair Eyewear, each one reinforcing a simple truth. Being early is not about speed. It is about seeing what others rationalize away. Precursor does not follow momentum. It recognizes formation before momentum exists.

Inside the firm, the structure mirrors the thesis. Small team, high exposure, direct access. No layers to hide behind, no delayed decisions. Founders get candor, not choreography. Support shows up where it matters: hiring, narrative, next-round positioning. The details that determine whether a company becomes a case study or a cautionary tale. In a startup ecosystem where surface-level support is easy to promise, Precursor leans into substance.

What separates Precursor Ventures is not just early capital. It is early conviction delivered with institutional consistency. They have become the first serious yes for founders who do not fit legacy patterns but are about to define new ones. That decision ripples outward. More diverse founders funded. More unconventional paths validated. More companies entering the market with a real shot at survival and scale.

And right now, that network is active. The Precursor portfolio is hiring across engineering, product, go-to-market, and operations. For builders who want proximity to raw creation, where ambiguity still creates edge, this is where the signal lives within the startup ecosystem.

Follow this firm. Study their founders. Track their plays.